Pulmonx Corporation (LUNG) Tops Q4 EPS by 12c

Pulmonx Corporation (NASDAQ: LUNG) reported Q4 EPS of ($0.33), $0.12 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $23.8 million versus the consensus estimate of $22.29 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
• Benchmark Reiterates Buy Rating on Alibaba (BABA) on Solid Q1 Earnings Beat
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings